Skip to main content



Registration and Disclosure of Clinical Trial Results in External Public Registries

Janssen publicly discloses information about its clinical trials in external public registries, such as These disclosure include:

  • Registering all pharmaceutical clinical trials conducted in patients (Phase 1b through phase 4) on external registries in accordance with specified requirements.
  • Upon receiving regulatory approval, disclosing clinical trial results of investigational studies in accordance with specific format and timeframe of local laws and regulations.
  • Disclosing company-sponsored pharmaceutical clinical trial results of approved products within one year of study completion, in accordance with and within the timeframe of applicable laws and regulations.